Search Results

Filter
  • 1-10 of  5,740 results for ""INTERLEUKIN-2""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Mathematical modeling and control of lung cancer with IL2 cytokine and anti-PD-L1 inhibitor effects for low immune individuals.

  • Authors : Ahmad A; Department of Mathematics, Ghazi University, D G Khan, Pakistan.; Kulachi MO

Subjects: Interleukin-2* ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy; Humans

  • Source: PloS one [PLoS One] 2024 Mar 14; Vol. 19 (3), pp. e0299560. Date of Electronic Publication: 2024 Mar 14 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.

  • Authors : Sedegah M; Agile Vaccines and Therapeutics, Naval Medical Research Center, Silver Spring, MD, United States of America.; Porter C

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Interferon-gamma*/Interferon-gamma*/Interferon-gamma*/immunology ; Interleukin-2*/Interleukin-2*/Interleukin-2*/immunology

  • Source: PloS one [PLoS One] 2022 Oct 17; Vol. 17 (10), pp. e0276241. Date of Electronic Publication: 2022 Oct 17 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Sustaining the T-cell activity in xenografted psoriasis skin.

  • Authors : Christensen PKF; LEO Pharma A/S, Ballerup, Denmark.; Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.

Subjects: Interleukin-2* ; Psoriasis*/Psoriasis*/Psoriasis*/pathology; Humans

  • Source: PloS one [PLoS One] 2023 Jan 17; Vol. 18 (1), pp. e0278390. Date of Electronic Publication: 2023 Jan 17 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.

  • Authors : Sedegah M; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Porter C

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/immunology ; Interferon-gamma*/Interferon-gamma*/Interferon-gamma*/immunology

  • Source: PloS one [PLoS One] 2022 Apr 07; Vol. 17 (4), pp. e0266691. Date of Electronic Publication: 2022 Apr 07 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy.

  • Authors : Charych D; Nektar Therapeutics, San Francisco, California, United States of America.; Khalili S

Subjects: Immunotherapy/Immunotherapy/Immunotherapy/*methods ; Interleukin-2/Interleukin-2/Interleukin-2/*analogs & derivatives ; Neoplasms/Neoplasms/Neoplasms/*therapy

  • Source: PloS one [PLoS One] 2017 Jul 05; Vol. 12 (7), pp. e0179431. Date of Electronic Publication: 2017 Jul 05 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.

  • Authors : Magee K; Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.; Marsh IR

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Interleukin-2/Interleukin-2/Interleukin-2/*therapeutic use ; Melanoma/Melanoma/Melanoma/*therapy

  • Source: PloS one [PLoS One] 2021 Aug 12; Vol. 16 (8), pp. e0255798. Date of Electronic Publication: 2021 Aug 12 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A.

  • Authors : Streltsova MA; Laboratory of Cell Interactions, Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow, Russian Federation.; Erokhina SA

Subjects: CD57 Antigens/CD57 Antigens/CD57 Antigens/*metabolism ; Interleukin-2/Interleukin-2/Interleukin-2/*pharmacology ; Killer Cells, Natural/Killer Cells, Natural/Killer Cells, Natural/*cytology

  • Source: PloS one [PLoS One] 2018 Dec 05; Vol. 13 (12), pp. e0208469. Date of Electronic Publication: 2018 Dec 05 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

TRI microparticles prevent inflammatory arthritis in a collagen-induced arthritis model.

  • Authors : Bassin EJ; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.; Buckley AR

Subjects: Microspheres*; Arthritis, Experimental/Arthritis, Experimental/Arthritis, Experimental/*prevention & control ; Interleukin-2/Interleukin-2/Interleukin-2/*pharmacology

  • Source: PloS one [PLoS One] 2020 Sep 23; Vol. 15 (9), pp. e0239396. Date of Electronic Publication: 2020 Sep 23 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Clausmarin A, Potential Immunosuppressant Revealed by Yeast-Based Assay and Interleukin-2 Production Assay in Jurkat T Cells.

  • Authors : Suauam P; Department of Microbiology, Faculty of Science, Chulalongkorn University, Phayathai Road, Pathumwan, Bangkok, 10330, Thailand.; Yingyongnarongkul BE

Subjects: Coumarins/Coumarins/Coumarins/*pharmacology ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*pharmacology ; Interleukin-2/Interleukin-2/Interleukin-2/*metabolism

  • Source: PloS one [PLoS One] 2015 Aug 27; Vol. 10 (8), pp. e0136804. Date of Electronic Publication: 2015 Aug 27 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.

  • Authors : Chesov D; Division of Pneumology and Allergology, State University of Medicine and Pharmacy 'Nicolae Testemitanu', Chisinau, Republic of Moldova; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.

Subjects: Antigens, Bacterial/Antigens, Bacterial/Antigens, Bacterial/*immunology ; Immunoassay/Immunoassay/Immunoassay/*methods ; Interferon-gamma/Interferon-gamma/Interferon-gamma/*metabolism

  • Source: PloS one [PLoS One] 2015 Mar 18; Vol. 10 (3), pp. e0120006. Date of Electronic Publication: 2015 Mar 18 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  5,740 results for ""INTERLEUKIN-2""